![Studijní programy](https://cdn.muni.cz/media/3757910/studijni-programy-student-jde-chodbou-masarykova-univerzita.jpg?mode=crop¢er=0.5,0.5&rnd=133754493890000000&heightratio=0.5&width=278)
Zde se nacházíte:
Informace o publikaci
Role of substance P in the cardiovascular system
Autoři | |
---|---|
Rok publikování | 2016 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | NEUROPEPTIDES |
Fakulta / Pracoviště MU | |
Citace | |
Doi | http://dx.doi.org/10.1016/j.npep.2015.12.005 |
Klíčová slova | Substance P; NK1 receptor; Cardiovascular regulation; Antagonist |
Popis | This article provides an overview of the structure and function of substance P signalling system and its involvement in the cardiovascular regulation. Substance P is an undecapeptide originating from TAC1 gen and belonging to the tachykinin family. The biological actions of substance P are mainly mediated through neurokinin receptor 1 since substance P is the ligand with the highest affinity to neurokinin receptor 1. Substance P is widely distributed within the central and peripheral nervous systems as well as in the cardiovascular system. Substance P is involved in the regulation of heart frequency, blood pressure and in the stretching of vessels. Substance P plays an important role in ischemia and reperfusion and cardiovascular response to stress. Additionally, it has been also implicated in angiogenesis, pain transmission and inflammation. The substance P/neurokinin receptor 1 receptor system is involved in the molecular bases of many human pathological processes. Antagonists of neurokinin receptor 1 receptor could provide clinical solutions for a variety of diseases. Neurokinin receptor 1 antagonists are already used in the prevention of chemotherapy induced nausea and vomiting. (C) 2015 Elsevier Ltd. All rights reserved. |